University of Arizona,

Phoenix, Arizona 85724

3 studies enrolling now · 12 studies all time

What they study most

COVID-19, Cardiac Resynchronization Therapy, Chronic Liver Disease, Cirrhosis, Liver, Cutaneous T-Cell Lymphoma, Epilepsy, Fragility Fracture, HER2-negative Breast Cancer, Heart Failure, Hepatocellular Carcinoma, His-bundle Pacing, Hormone Receptor-positive Breast Cancer

Studies at this site

• Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis — Recruiting now
• Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer — Recruiting now
• His-Bundle Corrective Pacing in Heart Failure — Recruiting now
• A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. — Running, not enrolling
• ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement — Running, not enrolling
• Surgiphor vs Saline Joints — Status unconfirmed
• FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) — Completed
• COVID-19 in Patients With Chronic Liver Diseases — Completed
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• TARGET Intracranial Aneurysm Coiling Registry — Status unconfirmed
• DEB-TACE for Hepatocellular Carcinoma — Stopped early
• Strategies for Aggressive Central Afterload Reduction in Patients With Heart Failure — Completed